Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Expected outcomes based on trial data: Average weight loss of 24.2% at 48 weeks (phase 2) Average weight loss of 28.7% at 68 weeks (phase 3, TRIUMPH-4) 100% of participants achieved 5% or greater weight loss 93% achieved 10% or greater 83% achieved 15% or greater Moderate weight loss protocol (8mg target) For researchers who want significant weight loss but have a lower tolerance for side effects, stopping the escalation at 8mg is a validated approach
Vitamin D increases calcium absorption and helps make bones stronger
Jump to: Why you should trust us At Innerbody Research, we extensively test each health service we review whenever possible, including Henry Meds
Generally follows the research-use only classification
Conclusion: Your Gut Deserves Better Than Guesswork GLP-1 medications represent one of the most significant advances in obesity and diabetes treatment in decades
FDA Warning Letters to GLP-1 Peptide Vendors (Sept 2025) In September 2025, the FDA issued more than 50 warning letters to U.S
US$ 29.01
US$ 22.67
US$ 27.85
US$ 24.51
US$ 23.05
US$ 24.05
US$ 23.32
US$ 21.44
US$ 26.21
